⟵ Back to Search Results

BGB-A317-30813-101

Active, not recruiting

A Study of BGB-30813 Alone or in Combination With Tislelizumab in Participants With Advanced or Metastatic Solid Tumors

Beigene Study ID info

BGB-A317-30813-101

ClinicalTrials.gov ID info

NCT05904496

EudraCT Number info

2023-503996-38

China Drug Trials ID info

CTR20233404

Study Overview

Sex: All

Age: 18 Years / N/A

No Study Documents

Study Overview

Sex: All

Age: 18 Years / N/A

No Study Documents